Martin Dreyling

26PUBLICATIONS
280CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyHaematologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 16, 2026
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel in 3L+ FL: 3-year update from TRANSCEND FL.

|Jul 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Jul 07, 2026
Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

|Jul 01, 2026
Clinical decision support in hematological malignancies using a case-grounded AI agent.

|Jun 23, 2026
Loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma.

|Oct 29, 2025
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.

Tom van Meerten, Marie José Kersten, Gloria Iacoboni

Pageof 5

Frequent Collaborators

7 joint publications

Eva Hoster

6 joint publications

Gilles Salles

5 joint publications

David W Scott

4 joint publications

Pier-Luigi Zinzani